P. Ribaud

B. Caillou, M. Tubiana, J. Misset, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

of Stage III and IV Lymphosarcoma and Reticulosarcoma Correlation of the Results with WHO Categorisation

F. Vassal, B. Caillou, M. Tubiana, 1978 .

MR and chemotherapy

N. Martin-Duverneuil, J. Chiras, C. Cognard, 1996, Neurology.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

R. Porcher, M. Robin, I. Casin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute Leukaemia Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality

H. Dombret, A. Baruchel, M. Robin, 2003 .

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

J. Mary, A. Toubert, M. Carmagnat, 2001, British journal of haematology.

Changing patterns of infections and antimicrobial susceptibilities.

K. Sepkowitz, G. Noskin, G. Maschmeyer, 2000, Oncology.

Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: distinction of two groups of patients according to predictable prognosis.

J. Misset, C. Jasmin, G. Mathé, 1978, Medical and pediatric oncology.

The Present State of “Curability” of Leukaemias Including Polycythaemia Vera

C. Jasmin, G. Mathé, L. Schwarzenberg, 1980 .

Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation.

R. Porcher, M. Robin, É. Azoulay, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients

H. Einsele, L. Pagano, M. Aljurf, 2017, The Journal of antimicrobial chemotherapy.

Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis

J. Latgé, F. Derouin, E. Gluckman, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.

S. Chevret, G. Socié, B. Arnulf, 2010, Chest.

Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients

J. Latgé, R. Porcher, A. Vekhoff, 2011, Journal of Clinical Microbiology.

Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft‐versus‐host disease after HLA identical sibling bone marrow transplants

R. Porcher, M. Robin, J. Larghero, 2007, British journal of haematology.

Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment.

J. Misset, G. Mathé, L. Schwarzenberg, 1982, Cancer detection and prevention.

Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality

H. Dombret, A. Baruchel, M. Robin, 2003, Bone Marrow Transplantation.

Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007.

R. Porcher, F. Suarez, E. Raffoux, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

CYSTECTOMY FOR SEVERE HEMORRHAGIC CYSTITIS IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1

V. Estrade, P. Sèbe, H. Bittencourt, 2000, Transplantation.

I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y

S. van der Werf, V. Enouf, D. Rousset, 2012, PloS one.

Mucormycosis in organ and stem cell transplant recipients.

Nina Singh, Hsin-Yun Sun, D. Kontoyiannis, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acquisition of Flucytosine, Azole, and Caspofungin Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant Recipient

C. Hennequin, G. Socié, F. Chapeland-leclerc, 2009, Antimicrobial Agents and Chemotherapy.

Epstein-barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy

A. Toubert, L. Adès, H. Esperou, 2004, Transplantation.

: with outcomes after HLA-identical sibling bone marrow transplantation Host defense and inflammatory gene polymorphisms are associated

R. Porcher, W. Silva, A. Latouche, 2011 .

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation.

J. Latgé, C. Chastang, F. Derouin, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors

L. Sedel, G. Socié, E. Gluckman, 1994, British journal of haematology.

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

A. Sulahian, P. Ribaud, S. Touratier, 2003, The New England journal of medicine.

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease.

F. Derouin, T. Leblanc, E. Gluckman, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis

A. Moreau, É. Azoulay, B. Schlemmer, 2011, Intensive Care Medicine.

The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?

J. Donay, P. Legrand, C. Cordonnier, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.

H. Einsele, M. Labopin, D. Niederwieser, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).

R. Porcher, M. Mohty, G. Socié, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes

J. Byrne, S. Mackinnon, A. Gratwohl, 2004, Bone Marrow Transplantation.

Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy

M. Ghannoum, G. Socié, P. Ribaud, 2008, Haematologica.

Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long‐term maintenance chemotherapy

J. Misset, G. Mathé, D. Machover, 1984 .

Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study

P. Rohrlich, V. Mallet, A. Roque-Afonso, 2019, Viruses.

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

P. Ljungman, C. Kibbler, C. Cordonnier, 2018, The Journal of antimicrobial chemotherapy.

Factors Influencing Outcome in De Novo Myelodysplastic Syndromes Treated by Allogeneic Bone Marrow Transplantation: A Long-Term Study

C. Chastang, X. Troussard, N. Ifrah, 2002 .

Indications and timing of allogeneic bone marrow transplantation in myelodysplastic syndromes.

V. Leblond, P. Ribaud, L. Sutton, 1997, Leukemia and Lymphoma.

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

Marie-Cécile Michallet, Bruno Lioure, C. Chastang, 1996 .

Short‐ and long‐term follow‐up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation

H. Esperou, G. Socié, E. Gluckman, 1997, British journal of haematology.

A Grading System Based on Severity of Infection to Predict Mortality in Allogeneic Stem Cell Transplant Recipients

S. Chevret, E. Gluckman, C. Cordonnier, 2006, Transplantation.

Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia.

P. Gaulard, V. Meignin, A. Janin, 1998, Transplantation.

High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.

R. Porcher, G. Socié, J. Molina, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

R. Porcher, M. Robin, S. Thépot, 2010, Leukemia.

Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation

M. Robin, A. Toubert, M. Carmagnat, 2014, Haematologica.

Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study.

F. Derouin, E. Gluckman, A. Sulahian, 1993, Bone marrow transplantation.

Hepatic veno‐occlusive disease

E. Gluckman, P. Ribaud, 1999, Pediatric transplantation.

Changes in causes of death over time after treatment for invasive aspergillosis

J. Wingard, R. Herbrecht, P. Ribaud, 2008, Cancer.

Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.

R. Rubin, D. Denning, J. Wingard, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kinetics and Metabol i sm of a New Fluoropyrimidine , 5 '-Deoxy-5f luorour

G. Mathé, J. Sommadossi, J. Cano, 2007 .

Failure of Zanamivir Therapy for Pneumonia in a Bone-Marrow Transplant Recipient Infected by a Zanamivir-Sensitive Influenza a (H1N1) Virus

J. Manuguerra, V. Lorin, S. van der Werf, 2007, Antiviral therapy.

Kinetics and metabolism of a new fluoropyrimidine, 5'-deoxy-5-fluorouridine, in humans.

G. Mathé, J. Sommadossi, J. Cano, 1983, Cancer research.

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.

J. Bourhis, M. Robin, M. Rybojad, 2012, Blood.

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.

C. Elie, M. Wolff, O. Lortholary, 2015, Journal of Antimicrobial Chemotherapy.

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

C. Heussel, A. Glasmacher, C. Solano, 2011, British journal of haematology.

Poor efficacy of amphotericin B‐based therapy in CNS aspergillosis

E. Thiel, E. Reed, P. Troke, 2007, Mycoses.

In vitro sensitivity of myeloblast clonogenic cells to doxorubicin, aclacinomycin A, and 4'-O-tetrapyranyl-doxorubicin: correlations with clinical responses.

V. Georgoulias, C. Jasmin, G. Mathé, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of cis-dichloro-trans-dihydroxy-bis(isopropylamine)platinum IV (CHIP).

J. Misset, G. Mathé, P. Ribaud, 1986, Oncology.

Long‐term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12)

M. Pébusque, G. Guasch, E. Gluckman, 2003, British Journal of Haematology.

Dynamics of cytomegalovirus populations harbouring mutations in genes UL54 and UL97 in a haematopoietic stem cell transplant recipient.

M. Robin, N. Schnepf, C. Deback, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

voriconazole treatment Improved outcome in central nervous system aspergillosis, using

E. Thiel, L. Corey, I. Lutsar, 2013 .

[Trial of androgen therapy in the treatment of non-lymphoblastic acute leukemia. First results].

P. Ribaud, J. Sotto, M. Michallet, 1976, La Nouvelle presse medicale.

Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

S. Chevret, H. Bittencourt, H. Esperou, 2001, Bone Marrow Transplantation.

Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections

M. Robin, A. Toubert, M. Carmagnat, 2010, Haematologica.

Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party.

H. Einsele, A. Alberti, P. Ljungman, 1994, Bone marrow transplantation.

Initial Liver Involvement in Acute GVHD is Predictive for Nonrelapse Mortality

R. Porcher, M. Robin, J. Mary, 2009, Transplantation.

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

H. Einsele, A. Bosi, P. Ljungman, 2003, Bone Marrow Transplantation.

Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial

M. Labopin, P. Ljungman, C. Cordonnier, 2015, Bone Marrow Transplantation.

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial.

H. Einsele, M. Labopin, D. Niederwieser, 2010, Vaccine.

Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT

H. Einsele, P. Ljungman, R. Martino, 2005, Bone Marrow Transplantation.

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

A. Thiébaut, U. Flückiger, C. Cordonnier, 2011, Bone Marrow Transplantation.

Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.

M. Robin, M. Mohty, N. Vey, 2008, International journal of antimicrobial agents.

EFFICACY AND SAFETY OF CASPOFUNGIN THERAPY IN CHILDREN WITH INVASIVE FUNGAL INFECTIONS

J. Stéphan, P. Ribaud, É. Merlin, 2006, The Pediatric infectious disease journal.

Liposomal Nystatin in Patients with Invasive Aspergillosis Refractory to or Intolerant of Amphotericin B

R. Sylvester, P. Moreau, G. Samonis, 2004, Antimicrobial Agents and Chemotherapy.

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

C. Cordonnier, S. Bretagne, P. Ribaud, 2004, Bone Marrow Transplantation.

Association of CD 34 cell dose with hematopoietic recovery , infections , and other outcomes after HLA-identical sibling bone marrow transplantation

S. Chevret, H. Bittencourt, H. Esperou, 2002 .

[Invasive aspergillosis and bone marrow allograft].

E. Gluckman, P. Ribaud, A. Devergie, 1994, Pathologie-biologie.

Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient.

E. Gluckman, F. Freymuth, F. Morinet, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.

A. Baruchel, G. Socié, P. Ribaud, 1995, Bone marrow transplantation.

Viral Respiratory Infections Diagnosed by Multiplex PCR after Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Incidence and Outcome

R. Porcher, M. Robin, G. Socié, 2014, Biology of Blood and Marrow Transplantation.

Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization

G. Damaj, G. Socié, E. Gluckman, 2000, Bone Marrow Transplantation.

H. Esperou, P. Ribaud, J. Marolleau, 2007 .

MR of cerebral aspergillosis in patients who have had bone marrow transplantation.

M. Laval-jeantet, A. Guermazi, Y. Miaux, 1995, AJNR. American journal of neuroradiology.

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Richard Sylvester, Raoul Herbrecht, John E Bennett, 2002, The New England journal of medicine.

Initial Liver Involvement in Acute Graft-Versus-Host Disease (GVHD) Predicts a Severe Acute Gvhd and Poor Long-Term Survival

R. Porcher, M. Robin, J. Mary, 2008 .

Allogeneic hematopoietic cell transplant in HCV-infected patients.

T. Asselah, P. Marcellin, M. Robin, 2008, Journal of hepatology.

Female Genital Chronic Graft-Versus-Host Disease: Importance of Early Diagnosis to Avoid Severe Complications

M. Robin, M. Rybojad, G. Socié, 2012, Transplantation.

Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours.

J. Misset, J. Montero, C. Jasmin, 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.

J. Perfect, C. White, R. Greene, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular Typing of Environmental and Patient Isolates of Aspergillus fumigatus from Various Hospital Settings

J. Latgé, E. Gluckman, G. Brücker, 1998, Journal of Clinical Microbiology.

Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients.

F. Derouin, T. Leblanc, P. Rousselot, 2001, The Journal of hospital infection.

Use and Limits of (1-3)-β-d-Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis

R. Porcher, F. Derouin, A. Sulahian, 2014, Journal of Clinical Microbiology.

Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.

M. Ghannoum, M. Robin, G. Socié, 2007, International journal of antimicrobial agents.

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.

Raoul Herbrecht, John E Bennett, R. Rubin, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

C. Beigelman-Aubry, L. Pagano, C. Heussel, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies

A. Baruchel, M. Labopin, M. Robin, 2007, Bone Marrow Transplantation.

Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.

R. Porcher, M. Robin, J. Larghero, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term outcome after bone marrow transplantation for severe aplastic anemia.

R. Porcher, M. Robin, J. Mary, 2004, Blood.

Monitoring of nosocomial invasive aspergillosis and early evidence of an outbreak using cumulative sum tests (CUSUM).

R. Porcher, F. Derouin, P. Ribaud, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Occurrence and Kinetics of False-Positive Aspergillus Galactomannan Test Results following Treatment with β-Lactam Antibiotics in Patients with Hematological Disorders

R. Porcher, F. Derouin, T. Leblanc, 2006, Journal of Clinical Microbiology.

Multicenter Outbreak of Infections by Saprochaete clavata, an Unrecognized Opportunistic Fungal Pathogen

F. Jardin, C. Ravel, H. Lanic, 2014, mBio.

Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.

H. Esperou, G. Socié, E. Gluckman, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

False positive galactomannan test after ice-pop ingestion.

P. Ribaud, J. Menotti, N. Guigue, 2013, The New England journal of medicine.

Diagnosis of IPA in HIV: the role of the chest X-ray and radiologist

K. Rabe, D. Denning, H. Zonderland, 2004, European Radiology.

Skin Microvascular Thrombosis in Fusarium Infection in Two Early Biopsied Cases

M. Robin, A. Janin, G. Socié, 2010, Case Reports in Dermatology.

Fungal infection prevention after hematopoietic cell transplantation

J. Wingard, T. Chiller, K. Marr, 2009, Bone Marrow Transplantation.

Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study

F. Derouin, G. Socié, E. Gluckman, 2005, Bone Marrow Transplantation.

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

H. Einsele, T. Klingebiel, P. Ljungman, 2001, Blood.

Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.

H. Einsele, P. Ljungman, C. Cordonnier, 1993, Bone marrow transplantation.

Breakthrough Invasive Fungal Infections (IFI) in patients treated with posaconazole as primary prophylaxis: a four year study

É. Azoulay, J. Molina, N. Lerolle, 2011 .

Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system

P. Moreau, R. Herbrecht, B. Dupont, 2011, Journal of medical economics.

Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.

F. Derouin, E. Gluckman, Y. Garin, 1994, Bone marrow transplantation.

Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders

L. Adès, H. Bittencourt, H. Esperou, 2005, Bone Marrow Transplantation.

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT

H. Einsele, P. Ljungman, D. Engelhard, 2004, Bone Marrow Transplantation.

Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation.

J. Cayuela, M. Robin, A. Toubert, 2008, The Journal of infectious diseases.

Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome

M. Robin, G. Socié, E. Gluckman, 2007, Haematologica.

Toxoplasmic pneumonitis leading to fatal acute respiratory distress syndrome after engraftment in three bone marrow transplant recipients.

V. Meignin, A. Janin, H. Esperou, 2001, Transplantation.

Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning

R. Porcher, J. Cayuela, M. Robin, 2012, Haematologica.

Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation.

S. Chevret, H. Bittencourt, H. Esperou, 2002, Blood.

Long-term outcome of hepatitis C infection after bone marrow transplantation.

T. Asselah, P. Marcellin, D. Valla, 2004, Blood.

A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors

M. Robin, H. Esperou, G. Socié, 2005, Leukemia.

Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation.

R. Porcher, M. Zago, W. Silva, 2002, Blood.

Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.

G. Mathé, P. Ribaud, M. Bonnay, 1981, Cancer treatment reports.

Evaluation of a new 5'-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat.

F. Derouin, S. Houzé, Y. Garin, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation

R. Tamouza, M. Busson, H. Esperou, 2002, Bone Marrow Transplantation.

R. Tamouza, M. Busson, G. Socié, 2002 .

Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas

F. Vassal, J. Misset, C. Jasmin, 2004, Cancer Chemotherapy and Pharmacology.

Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.

J. Misset, C. Jasmin, G. Mathé, 1978, Cancer treatment reports.

Double cord blood transplantation in patients with high risk bone marrow failure syndromes

M. Robin, J. Larghero, G. Socié, 2008, British journal of haematology.

Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.

M. Robin, J. Larghero, G. Socié, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.

Xiaxin Li, A. Janin, H. Esperou, 2004, Blood.

Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation.

S. Chevret, I. Yakoub-Agha, E. Wattel, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Polyomaviruses KI and WU in Immunocompromised Patients with Respiratory Disease

G. Socié, P. Ribaud, A. Bergeron, 2009, Emerging Infectious Diseases.

Polyomaviruses KI and WU in immunocompromised patients with respiratory disease.

G. Socié, P. Ribaud, A. Bergeron, 2009, Emerging infectious diseases.

Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease.

R. Porcher, M. Robin, N. Kapel, 2012, Blood.

Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia

R. Porcher, J. Larghero, M. Zago, 2009, Leukemia.

Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression.

J. Mary, V. Meignin, L. Adès, 2004, Blood.

Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation

M. Robin, J. Larghero, G. Socié, 2007, British journal of haematology.

Impact of the source of hematopoietic stem cell in unrelated transplants: Comparison between 10/10, 9/10‐HLA matched donors and cord blood

R. Porcher, M. Robin, J. Larghero, 2015, American journal of hematology.

Low-dose Thoracoabdominal Irradiation for the Treatment of Refractory Chronic Graft-versus-Host Disease

M. Robin, H. Esperou, G. Socié, 2005, Transplantation.

Polyomavirus nephropathy in the native kidneys of an unrelated cord blood transplant recipient followed by a disseminated polyomavirus infection.

M. Robin, C. Oudot, H. Esperou, 2006, Transplantation.

Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation

H. Esperou, G. Socié, E. Gluckman, 1998, Leukemia.

Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors

R. Porcher, M. Robin, J. Larghero, 2014, Haematologica.

Impact of comorbidity indexes on non-relapse mortality

R. Porcher, M. Robin, G. Socié, 2008, Leukemia.

The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.

S. Chevret, M. Robin, A. Janin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Primary Epstein-Barr virus infection with pneumonia transmitted by allogeneic bone marrow after transplantation.

M. Robin, M. Carmagnat, P. Teira, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research.

H. Atkins, M. Horowitz, P. Tiberghien, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT

M. Robin, A. Toubert, M. Busson, 2014, Bone Marrow Transplantation.

Nephrotic syndrome associated with graft rejection after unrelated double cord blood transplantation.

M. Robin, G. Socié, V. Rocha, 2010, Transplantation.

An intensive care chemo- or chemoimmunotherapy regimen for patients with intermediate and poor-prognosis acute lymphatic leukemia and leukemic lymphoblastic lymphosarcoma: preliminary results with 14-month median follow-up.

J. Misset, C. Jasmin, G. Mathé, 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment.

R. Porcher, M. Robin, G. Socié, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation

R. Porcher, M. Robin, A. Toubert, 2012, Transplantation.

Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.

J. Misset, C. Jasmin, G. Mathé, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma

J. Misset, C. Jasmin, G. Mathé, 1978, Cancer Chemotherapy and Pharmacology.

Is it justified to neglect the role of chemotherapy in the treatment of prostatic cancer?

C. Jasmin, P. Ribaud, 1987, Progress in clinical and biological research.

CLINICAL RESULTS WITH CISPLATIN ANALOGS

G. Mathé, F. Muggia, P. Ribaud, 1980 .

Some new chemotherapeutic agents and combinations possibly available for new adjuvant therapies of minimal disease.

J. Misset, G. Mathé, D. Machover, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Increased Incidence of Cytomegalovirus Retinitis After Allogeneic Hematopoietic Stem Cell Transplantation

M. Robin, H. Esperou, G. Socié, 2007, Transplantation.

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

S. Chevret, M. Robin, G. Socié, 2012, Bone Marrow Transplantation.

Respiratory Symptoms Occurring 4 Months After Allogeneic Hematopoietic Stem Cell Transplantation

V. Meignin, S. Feuillet, P. Ribaud, 2011 .

Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation.

H. Bittencourt, G. Socié, E. Gluckman, 2001 .

Treatment of T‐prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation

H. Bittencourt, G. Socié, E. Gluckman, 2001, European journal of haematology.

Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation.

S. Chevret, Anne Bergeron, P. Ribaud, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle.

C. Chastang, J. Reiffers, X. Troussard, 1996, Blood.

The PTPN22 R620W Polymorphism is Associated With Severe Bacterial Infections After Human Leukocyte Antigen Geno-Identical Haematopoietic Stem-Cell Transplantations

A. Toubert, M. Busson, G. Socié, 2008, Transplantation.

correspondence: Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis

M. Robin, H. Esperou, G. Socié, 2010, British journal of haematology.

Epidemiology of S pneumoniae Infection in Hematology Patients in Ile de France: Serotypes Covered by the Polysaccharide 23-Valent (PS23) and the Heltavalent Conjugate Vaccine.

J. Donay, P. Legrand, C. Cordonnier, 2007 .

Effective graft‐versus‐leukaemia effect after allogeneic stem cell transplantation using reduced‐intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia

J. Cayuela, R. Storb, H. Esperou, 2003, British journal of haematology.

Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group.

H. Dombret, S. Leprêtre, R. Gressin, 2021, Clinical lymphoma, myeloma & leukemia.

Malignant diseases after allogeneic bone marrow transplantation: an updated overview.

M. Henry-Amar, G. Socié, E. Gluckman, 1994, Nouvelle revue francaise d'hematologie.

Prospective Assessment of Bone Turnover and Clinical Bone Diseases After Allogeneic Hematopoietic Stem-Cell Transplantation

R. Porcher, M. Robin, G. Socié, 2010, Transplantation.

Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.

H. Tapiero, J. Misset, D. Machover, 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Treatment of lymphoid neoplasias with interferon. II. Human leucocyte alpha-interferon in chronic lymphatic leukemia (CLL). PHase I-II trial.

J. Misset, C. Jasmin, G. Mathé, 1982, Anticancer research.

Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis

R. Porcher, M. Robin, G. Socié, 2012, Haematologica.

Comparison of PCR-Enzyme-Linked Immunosorbent Assay and Real-Time PCR Assay for Diagnosis of an Unusual Case of Cerebral Toxoplasmosis in a Stem Cell Transplant Recipient

F. Derouin, L. Adès, E. Gluckman, 2003, Journal of Clinical Microbiology.

Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation

D. Gossot, M. Robin, V. Meignin, 2011, European Respiratory Journal.

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation

S. Chevret, L. Adès, H. Esperou, 2007, Bone Marrow Transplantation.

Hematon, a multicellular functional unit in normal human bone marrow: structural organization, hemopoietic activity, and its relationship to myelodysplasia and myeloid leukemias.

J. Misset, G. Mathé, M. Benavides, 1990, Experimental hematology.

Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.

H. Dombret, H. Jacquier, J. Donay, 2014, The Journal of antimicrobial chemotherapy.

Phase I trials in clinical oncostatic pharmacology

G. Mathé, P. Ribaud, 2004, Cancer Chemotherapy and Pharmacology.

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

C. Heussel, A. Glasmacher, C. Solano, 2011, British journal of haematology.

Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU.

P. Schein, J. Misset, C. Jasmin, 1982, European journal of cancer & clinical oncology.

Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.

J. Misset, G. Mathé, P. Ribaud, 1992, Cancer Detection and Prevention.

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients

B. Autran, A. Thiébaut, J. Bay, 2013, Vaccine.

Topical imiquimod for recurrent acyclovir-resistant HSV infection.

J. Molina, P. Ribaud, V. Martinez, 2006, The American journal of medicine.

Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.

J. Misset, J. Horoszewicz, C. Jasmin, 1982, Anticancer research.

Response assessment in invasive aspergillosis.

R. Porcher, A. Sulahian, E. Raffoux, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune Response to the 23-Valent Polysaccharide Pneumococcal Vaccine (PPV23) after the 7-Valent Conjugate Vaccine (PCV7) in Allogeneic Stem Cell Transplant (SCT) Recipients: Results of the EBMT IDWP01 Trial

H. Einsele, M. Labopin, D. Niederwieser, 2008 .

Experimental ultrastructural and X-ray microanalysis study of cisplatin in the rat: intracellular localization of platinum.

G. Mathé, P. Gallé, J. Berry, 1982, Cancer treatment reports.

Letters to the Editor Multidrug-Resistant Trichosporon asahii Isolates Are Susceptible to Voriconazole

R. Rubin, D. Denning, J. Wingard, 2003 .

Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure

É. Azoulay, B. Schlemmer, N. Boissel, 2011, Infection.

Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long‐term maintenance chemotherapy

J. Misset, G. Mathé, D. Machover, 1984, Cancer.

SPLENECTOMY AND KARYOTYPIC CONVERSION IN CHRONIC MYELOID LEUKÆMIA

F. Vassal, J. Misset, C. Jasmin, 1979, The Lancet.

Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.

H. Tapiero, J. Misset, D. Machover, 1984, Cancer treatment reports.

Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria

H. Esperou, G. Socié, E. Gluckman, 1999, British journal of haematology.

Reply to "Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation".

P. Ribaud, A. Bergeron, C. de Margerie-Mellon, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.

V. Georgoulias, J. Misset, G. Mathé, 1983, Anticancer Research.

Phase I‐II study of aclarubicin for treatment of acute myeloid leukaemia

F. Vassal, H. Tapiero, J. Misset, 1987, European journal of haematology. Supplementum.

An oriented phase II trial of THP-adriamycin in breast carcinoma.

H. Tapiero, J. Misset, G. Mathé, 1986, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Tibial artery thrombosis due to varicella zoster virus in a transplant recipient under cyclosporine.

D. Farge, E. Gluckman, P. Ribaud, 1993, European Journal of Medicine.

Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

D. Denning, F. Dromer, E. Hart, 2006, The Journal of antimicrobial chemotherapy.

Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation.

J. Cayuela, M. Robin, A. Toubert, 2008, The Journal of infectious diseases.

Relationship between HLA alleles and cytomegalovirus infection after allogenic hematopoietic stem cell transplant.

S. Chevret, H. Bittencourt, H. Esperou, 2001, Blood.

Initial Liver Involvement in Acute GVHD is Predictive for Nonrelapse Mortality

R. Porcher, M. Robin, J. Mary, 2009, Transplantation.

Reply to Verweij et al

R. Rubin, D. Denning, J. Wingard, 2007 .

Mucormycosis in organ and stem cell transplant recipients.

Nina Singh, Hsin-Yun Sun, D. Kontoyiannis, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Breakthrough zygomycosis following empirical caspofungin treatment: report of two patients with leukemia and literature review

H. Dombret, O. Lortholary, N. Boissel, 2010 .

Impact of comorbidity indexes on non-relapse mortality

R. Porcher, M. Robin, G. Socié, 2008, Leukemia.